HHSN261201500003I-75N91018F00073
Delivery Order
Overview
Government Description
PDX PANELS FROM COMMON TUMORS
Awardee
Awarding / Funding Agency
Place of Performance
Frederick, MD 21702 United States
Pricing
Cost Plus Fixed Fee
Set Aside
None
Extent Competed
Not Competed
Related Opportunity
Analysis Notes
Amendment Since initial award the Potential End Date has been extended from 09/27/23 to 09/25/27 and the Potential Award value has increased 2% from $66,581,973 to $67,882,919.
Sole Source This Delivery Order was awarded sole source to Leidos Biomedical Research.
Subcontracting Plan This Delivery Order has an Individual Subcontract Plan. The Department of Health and Human Services has an overall small business subcontracting goal of 32%
Sole Source This Delivery Order was awarded sole source to Leidos Biomedical Research.
Subcontracting Plan This Delivery Order has an Individual Subcontract Plan. The Department of Health and Human Services has an overall small business subcontracting goal of 32%
Leidos Biomedical Research was awarded
Delivery Order 75N91018F00073 (75N910-18-F-00073)
for Pdx Panels From Common Tumors
worth up to $67,882,919
by National Cancer Institute
in September 2018.
The contract
has a duration of 9 years and
was awarded
through solicitation Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC)
full & open
with
NAICS 561210 and
PSC M1HA
via sole source acquisition procedures.
Status
(Open)
Last Modified 9/26/23
Period of Performance
9/28/18
Start Date
9/25/27
Current End Date
9/25/27
Potential End Date
Obligations
$67.9M
Total Obligated
$67.9M
Current Award
$67.9M
Potential Award
Award Hierarchy
Indefinite Delivery Contract
Delivery Order
HHSN261201500003I-75N91018F00073
Subcontracts
Activity Timeline
Labor Services Billing
Annual labor billing rates and FTE reported for HHSN261201500003I-75N91018F00073
| Year | Services Invoiced | Hours | FTE | Blended Rate |
|---|---|---|---|---|
| 2019 | $4,854,362 | 37,179.7 | 17.9 | $130.56 |
| 2020 | $6,457,157 | 53,835.2 | 25.9 | $119.94 |
| 2021 | $4,794,511 | 32,449.6 | 15.6 | $147.75 |
| 2022 | $6,250,834 | 38,601.1 | 18.5 | $161.93 |
| 2023 | $18,742,614 | 76,448.1 | 36.7 | $245.17 |
Subcontract Awards
Disclosed subcontracts for HHSN261201500003I-75N91018F00073
Opportunity Lifecycle
Procurement history for HHSN261201500003I-75N91018F00073
Transaction History
Modifications to HHSN261201500003I-75N91018F00073
People
Suggested agency contacts for HHSN261201500003I-75N91018F00073
Competition
Number of Bidders
Not Applicable
Solicitation Procedures
Sole Source
Other Than Full and Open Competition
Follow-On Contract
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Individual Subcontract Plan
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
HV8BH9BPG8Y9
Awardee CAGE
3LYK6
Agency Detail
Awarding Office
75N910 NIH NCI
Funding Office
75N910
Created By
hhsdmills1
Last Modified By
hhsskeasey
Approved By
hhsskeasey
Legislative
Legislative Mandates
None Applicable
Performance District
MD-06
Senators
Benjamin Cardin
Chris Van Hollen
Chris Van Hollen
Representative
David Trone
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) | Health research and training | Other services from non-Federal sources (25.2) | $82,275,543 | 75% |
| National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) | Health research and training | Research and development contracts (25.5) | $26,707,853 | 25% |
Modified: 9/26/23